A Mitochondrial Power Play in Lymphoma

Slides:



Advertisements
Similar presentations
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Advertisements

Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
IPSC Crowdsourcing: A Model for Obtaining Large Panels of Stem Cell Lines for Screening Mahendra Rao Cell Stem Cell Volume 13, Issue 4, Pages (October.
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung Zvi Granot, Erik Henke, Elizabeth A. Comen, Tari A. King, Larry Norton, Robert Benezra.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Sirt4: The Glutamine Gatekeeper
Cancer: Inappropriate Expression of Stem Cell Programs?
Building better therapy for children with acute lymphoblastic leukemia
We Contain Multitudes: The Protean Face of Retinoblastoma
“Atypical” Regulation of Hedgehog-Dependent Cancers
The Metabolic Milieu of Metastases
A Pro-metastatic tRNA Pathway
Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension
Taking the Stress out of Melanoma
Metastasis gets site specific
Accelerating drug discovery: Open source cancer cell biology?
Anaerobicizing into Pluripotency
HSF1 in Translation Cancer Cell
Volume 14, Issue 2, Pages (August 2008)
Volume 11, Issue 4, Pages (April 2007)
Metabolic Makeover for HSCs
A Sweet New Role for EGFR in Cancer
When Deletions Gain Functions: Commandeering Epigenetic Mechanisms
Annapoorni Rangarajan, Sue J. Hong, Annie Gifford, Robert A. Weinberg 
DAISY: Picking Synthetic Lethals from Cancer Genomes
Volume 26, Issue 1, Pages 1-2 (July 2014)
The Wind God Promotes Lung Cancer
Volume 13, Issue 1, Pages 1-2 (January 2008)
A Radical Role for p38 MAPK in Tumor Initiation
Can Treating the SYK Cell Cure Leukemia?
Metastasis-Promoting Immunity: When T Cells Turn to the Dark Side
The AML Salad Bowl Cancer Cell
Radiation resistance and stem-like cells in brain tumors
Coming up for air: HIF-1 and mitochondrial oxygen consumption
Resistance Is Futile: Targeting Mitochondrial Energetics and Metabolism to Overcome Drug Resistance in Cancer Treatment  Claudie Bosc, Mary A. Selak,
Understanding the Intersections between Metabolism and Cancer Biology
The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Heike Döppler, Peter Storz  Cell Metabolism 
Volume 26, Issue 6, Pages (December 2014)
A New “Brew” of MALT1 Inhibitors
The LKB1-AMPK Pathway—Friend or Foe in Cancer?
Cancer Metabolism: Is Glutamine Sweeter than Glucose?
Mitochondria and Cancer
Rewiring Bacteria, Two Components at a Time
Wissam Assaily, Samuel Benchimol  Cancer Cell 
LKB1 and Src: Antagonistic Regulators of Tumor Growth and Metastasis
Hard Times for Oncogenic BRAF-Expressing Melanoma Cells
NO Signals from the Cancer Stem Cell Niche
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
Volume 14, Issue 4, Pages (October 2008)
Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
Developing Neutrophils Must Eat…Themselves!
Volume 35, Issue 6, Pages (December 2011)
Sirt4: The Glutamine Gatekeeper
To Infinium, and Beyond! Cancer Cell
Volume 10, Issue 3, Pages (September 2006)
All Roads Lead to the Ribosome
Radiation resistance and stem-like cells in brain tumors
ATMIN: A New Tumor Suppressor in Developing B Cells
There's a Time and a Place for MYCN
Volume 17, Issue 2, Pages (February 2010)
Ibrutinib Treatment of CLL: The Cancer Fights Back
Pharmacological Rescue of p53 in Cancer Therapy: Widening the Sensitive Tumor Spectrum by Targeting MDMX  Jean-Christophe Marine  Cancer Cell  Volume.
Volume 12, Issue 6, Pages (December 2007)
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
The AML Salad Bowl Cancer Cell
Presentation transcript:

A Mitochondrial Power Play in Lymphoma Ralph J. DeBerardinis  Cancer Cell  Volume 22, Issue 4, Pages 423-424 (October 2012) DOI: 10.1016/j.ccr.2012.09.023 Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 Variable Reliance on Oxidative Phosphorylation in DLBCL Cells produce ATP from glycolysis (blue pathway) and oxidative phosphorylation (OxPhos, green). Cancer cell lines vary according to what fraction of their total ATP comes from each pathway, as shown on the spectrum at the bottom. A subset of DLBCL tumors was defined by high expression of genes related to OxPhos. These cells produced most of their ATP from OxPhos and required this pathway for survival and growth. Non-OxPhos cells, which did not share this gene expression signature, produced a higher fraction of their ATP from glycolysis, and were resistant to OxPhos inhibition. Abbreviation: TCA, tricarboxylic. Cancer Cell 2012 22, 423-424DOI: (10.1016/j.ccr.2012.09.023) Copyright © 2012 Elsevier Inc. Terms and Conditions